These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4211031)

  • 21. [Prevention of hemolytic disease in newborn infants].
    Schneider J
    Med Klin; 1969 Mar; 64(13):578-80. PubMed ID: 4182137
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anti-D-prevention within the scope of a regional work-community].
    Luboldt W; Lohmeyer H; Schmolling E; Hoize J; Neumann H
    Med Klin; 1970 May; 65(22):1082-8. PubMed ID: 5000118
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of maternal sensitization to the Rh factor.
    N Engl J Med; 1972 Jul; 287(4):197-8. PubMed ID: 4624455
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention of Rh-immunization in Sweden.
    Bartsch FK; Sandberg L; Unander M
    Pathologica; 1972; 64(929):111-4. PubMed ID: 4210412
    [No Abstract]   [Full Text] [Related]  

  • 25. Rh hemolytic disease of the newborn: its cause and prevention.
    Pollack W
    Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunosuppressive mechanism and effect of immunoglobulins Anti D and Anti DK (IgG) in the prevention of hemolytic disease of the newborn caused by Rh incompatibility].
    Skrzypulec ZA
    Zentralbl Gynakol; 1973 Mar; 95(12):402-10. PubMed ID: 4634158
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy and prevention of hemolytic disease of the newborn caused by the Rh factor].
    Kogoj-Bakic V
    Lijec Vjesn; 1970 Nov; 92(11):1323-31. PubMed ID: 4332439
    [No Abstract]   [Full Text] [Related]  

  • 28. [Our experience in the prevention of Rh immunization with immunoglobulin anti-D].
    Coletta A; Belletti F; Cardona A; Cammarota M; De Ninno F; Pennino G; Toro L; Miceli G
    Minerva Ginecol; 1974 Jul; 26(7):404-6. PubMed ID: 4213550
    [No Abstract]   [Full Text] [Related]  

  • 29. Prenatal antibody screening and use of Rho(D) immune globulin (human).
    Wis Med J; 1971 Nov; 70(11):235-6. PubMed ID: 5000134
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of Rh hemolytic disease.
    Pollack W; Gorman JG; Freda VJ
    Prog Hematol; 1969; 6():121-47. PubMed ID: 4976484
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of RH sensitization in Switzerland].
    Bamelli GP
    Pathologica; 1972; 64(929):101-3. PubMed ID: 4210411
    [No Abstract]   [Full Text] [Related]  

  • 32. Ten-year experience with high titer anti-D plasma for the prevention of Rh isoimmunization.
    Hamilton EG
    Obstet Gynecol; 1972 Nov; 40(5):692-6. PubMed ID: 4628388
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of some social factors on perinatal mortality due to hemolytic disease of the newborn caused by Rh incompatibility].
    Paladini A; Di Martino D; De Luca P; Rascio B; Di Lieto A
    Arch Ostet Ginecol; 1969 Dec; 74(6):449-60. PubMed ID: 5000273
    [No Abstract]   [Full Text] [Related]  

  • 34. Protection against Rh sensitization and prevention of erythroblastosis fetalis.
    Diamond LK
    Pediatrics; 1968 Jan; 41(1):1-4. PubMed ID: 4965727
    [No Abstract]   [Full Text] [Related]  

  • 35. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Aug; 46(8):1271-5. PubMed ID: 16934058
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of Rh immunization.
    Can Med Assoc J; 1970 Jul; 103(2):180-1. PubMed ID: 4193862
    [No Abstract]   [Full Text] [Related]  

  • 37. [Our preliminary experience in the field of serum prevention of anti-HDN hemolytic disease of the newborn by means of anti-D immunoglobulins].
    Arrotta U; Cardinale F; Sideri L
    Minerva Ginecol; 1972 Dec; 24(12):619-26. PubMed ID: 4211544
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of Rh sensitization. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1971; 468():3-36. PubMed ID: 4999558
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevention of hemolytic disease of the newborn with anti-D administration to the mother. 2].
    Dtsch Med Wochenschr; 1968 Jun; 93(24):1176-9. PubMed ID: 4967928
    [No Abstract]   [Full Text] [Related]  

  • 40. [In favor of a national program of prevention of Rh-hemolytic disease of the newborn].
    Dambrosio F
    Ann Ostet Ginecol Med Perinat; 1972 Feb; 93(2):114-7. PubMed ID: 4630080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.